SlideShare a Scribd company logo
Collaboration Within and
between Countries
“Working together against
Fake Medicines”
by
Bejon Misra, Founder Director
Partner for Safe Medicines (PSM) India
Friday 6th February 2015
Taipei, Taiwan
Mission
• A public health group committed to the safety
of prescription drugs and protecting
consumers against spurious and not-of-
standards or otherwise unsafe medicines
Vision
• Just One Unsafe Medicine Threatens Patient
Safety… we all must work together to educate
and to help protect patients in India and
around the globe
PSM India
Overarching Objectives
•To adopt modern technology to empower and enable
Indian consumers to access safe medicines as a patient’s
right to safety and informed choice
•To integrate spurious with not-of-standards and unsafe
medicines as per the existing laws in India
•To ensure consumer safety prevails as the priority by
engaging with all the stakeholders in an equitable manner,
with a focus on the poor and vulnerable consumers in
India
PSM India Board of Trustees
1. Secretary General, Indian Medical Association (IMA)
2. Former President, All India Women’s Conference (AIWC)
3. Former Chief Information Commissioner, Govt. of India, Chairman
4. Chairman of Healthy You Foundation (Consumer Organisation)
5. Supreme Court Of India Advocate
6. Former Secretary to the Govt. of India
7. Founder & Trustee, Consumer Online Foundation
8. Former Chief of Customs & Excise, Govt. of India
9. WHO Consultant
10. Pharmaceutical Regulatory Consultant
11. Medical Practitioner and Retired from Indian Defence Services
12. Former Vice President of International Pharmaceutical Federation
13. Director, Cell for Consumer Education and Advocacy
14. Founder of Private Hospital Dealing with Emergency Care, Vice Chairman
15. Chairman, THINK TANK Pharma Industry Forum
15 Members with Broad Experience
PSM India: The Beginning
• Concept:
– Emerged from brainstorming session organized by PSM USA based on
individual meetings with key stakeholders with interest in PSM
• Steering Committee:
– Formal board members based on organization meeting prior to launch
• Immediate Goals:
– Build strong coalition with all stakeholders engaged in the medicine
supply chain
– Make PSM patient centric with support from government
– Make PSM dedicated to patient safety, quality medicines & healthcare
Building PSM India
• Process:
– Consulted and re-consulted the stakeholders, especially government
and consumer/patient groups, to build PSM toward addressing key
concerns about unsafe medicines
– For board members, identified individuals and organizations with an
excellent track record on its competence and reach. Ensured
participation by entities in the medicine supply chain
• Government involvement
– Government officials always invited to Board meetings even though they
are not board members
– Joint educational and outreach activities with PSM
– Co-share resources for organizing events, workshops and training
initiatives
• Other stakeholders
– Lawyers, law enforcers, research institutions also invited as observers
Lessons Learned
• Put forward PSM objectives in open manner and engage
all stakeholders from the beginning to build support and
cooperation
• Create good vibrant website with regular newsletter to
push out
• Organize events on range of health care topics, but
connect to the issue of tackling counterfeit medicines in
the supply chain
• Maintain regular connection with government
• Recognize and give credit to organizations playing a
positive role in advancing the objectives of PSM
Advice for Similar Alliances in other Countries
• Make sure the PSM is driven by local leadership and interests
• Do not allow PSM to be viewed as an initiative of any one Cluster or
sector
• Avoid straying into issues that are not clearly related to the fight
against fake medicines and educating the public about the risks
• Do not make it look like a club of a few elite institutions or individuals
• Do not ignore your detractors or critics
 Aggressive but well-calibrated organization led to successful
partnerships including all levels of Indian government
 Indian pharmaceutical industry buy-in
 Public education campaign with regular Newsletter, dynamic
website and toll-free 24/7 Helpline
 As a result, Indian consumers finally have the ability to educate
themselves on the dangers of fake medicines
 Indian government is more aware of risks and more willing to
crack down on counterfeit producers
PSM India: Progress
PSM India: The Future
Connect and empower the consumer:
• More than 900 million consumers have mobile phones in India
• More than 1 billion consumers with access to television/radio
What and how to communicate?
• How to procure safe medicines (generic & branded) from secured
sources
• Educate consumers to report adverse reactions from medicines
• Strengthen the national pharmacovigilance system
• Create champions as whistleblowers to report unethical practices
and expose the culprits
PSM India to Work on Patient’s Charter
on Access to Safe Medicines
Standards
Choice
Accessibility
Non-discrimination
Transparency
Accountability
Information
Quality of service
Consumer Empowerment is the Key
Demo
manufacturer
authenticates
genuine pack of
XXXX. Batch No.
XXXX Thank you
for verifying your
THANK YOU
http://www.safemedicinesindia.in/

More Related Content

What's hot

Drug regulatory agency of pakistan ---------
Drug regulatory agency of pakistan ---------Drug regulatory agency of pakistan ---------
Drug regulatory agency of pakistan ---------Searle Pakistan Limited
 
Prevention of counterfeit medicine
Prevention of counterfeit medicinePrevention of counterfeit medicine
Prevention of counterfeit medicineNitin Patel
 
African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation PharmaAfrica
 
The Falsified Medicines Directive - Regulation Driving Digitisation
The Falsified Medicines Directive - Regulation Driving DigitisationThe Falsified Medicines Directive - Regulation Driving Digitisation
The Falsified Medicines Directive - Regulation Driving DigitisationAegate
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industryApurv Singh
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...TGA Australia
 
OTC Drug Market - Future Growth Driver for IPM
OTC Drug Market - Future Growth Driver for IPMOTC Drug Market - Future Growth Driver for IPM
OTC Drug Market - Future Growth Driver for IPMShubhankar Mazumdar
 
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Market
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging MarketREIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Market
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Marketmohamed saad
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine ShortagesTGA Australia
 
Pharmaceutical Industry Analysis 2013
Pharmaceutical Industry Analysis 2013Pharmaceutical Industry Analysis 2013
Pharmaceutical Industry Analysis 2013Propane Studio
 
Revisiting Recommendations on Drug Resistance from Past Studies
Revisiting Recommendations on Drug Resistance from Past StudiesRevisiting Recommendations on Drug Resistance from Past Studies
Revisiting Recommendations on Drug Resistance from Past Studiescgdev
 
Noor Mehar presentation
Noor Mehar presentationNoor Mehar presentation
Noor Mehar presentationKalim Ullah
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1TGA Australia
 
Medicines Verification Systems in Europe – a perspective from wholesale distr...
Medicines Verification Systems in Europe – a perspective from wholesale distr...Medicines Verification Systems in Europe – a perspective from wholesale distr...
Medicines Verification Systems in Europe – a perspective from wholesale distr...László Árvai
 
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...semanticsconference
 
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposium
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposiumAegate Symposium Frankfurt June 2015 - Loof frankfurt symposium
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposiumAegate
 

What's hot (20)

Session1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European UnionSession1: Patrick Deboyser, European Union
Session1: Patrick Deboyser, European Union
 
Drug regulatory agency of pakistan ---------
Drug regulatory agency of pakistan ---------Drug regulatory agency of pakistan ---------
Drug regulatory agency of pakistan ---------
 
Prevention of counterfeit medicine
Prevention of counterfeit medicinePrevention of counterfeit medicine
Prevention of counterfeit medicine
 
African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation African Medicines Regulatory Harmonisation
African Medicines Regulatory Harmonisation
 
Good Governance for Medicines (GGM) programme in the Region - implementation ...
Good Governance for Medicines (GGM) programme in the Region - implementation ...Good Governance for Medicines (GGM) programme in the Region - implementation ...
Good Governance for Medicines (GGM) programme in the Region - implementation ...
 
The Falsified Medicines Directive - Regulation Driving Digitisation
The Falsified Medicines Directive - Regulation Driving DigitisationThe Falsified Medicines Directive - Regulation Driving Digitisation
The Falsified Medicines Directive - Regulation Driving Digitisation
 
Pharmaceutical industry
Pharmaceutical industryPharmaceutical industry
Pharmaceutical industry
 
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
 
OTC Drug Market - Future Growth Driver for IPM
OTC Drug Market - Future Growth Driver for IPMOTC Drug Market - Future Growth Driver for IPM
OTC Drug Market - Future Growth Driver for IPM
 
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Market
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging MarketREIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Market
REIMBURSEMENT ISSUES FOR ONCOLOGY DRUGS- Emerging Market
 
Reporting of Medicine Shortages
Reporting of Medicine ShortagesReporting of Medicine Shortages
Reporting of Medicine Shortages
 
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
ABPI briefing on the Falsified Medicines Directive (FMD) FEB 2017
 
Pharmaceutical Industry Analysis 2013
Pharmaceutical Industry Analysis 2013Pharmaceutical Industry Analysis 2013
Pharmaceutical Industry Analysis 2013
 
Revisiting Recommendations on Drug Resistance from Past Studies
Revisiting Recommendations on Drug Resistance from Past StudiesRevisiting Recommendations on Drug Resistance from Past Studies
Revisiting Recommendations on Drug Resistance from Past Studies
 
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
ABPI briefing on the Falsified Medicines Directive (FMD) OCT 2016
 
Noor Mehar presentation
Noor Mehar presentationNoor Mehar presentation
Noor Mehar presentation
 
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 1
 
Medicines Verification Systems in Europe – a perspective from wholesale distr...
Medicines Verification Systems in Europe – a perspective from wholesale distr...Medicines Verification Systems in Europe – a perspective from wholesale distr...
Medicines Verification Systems in Europe – a perspective from wholesale distr...
 
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
 
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposium
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposiumAegate Symposium Frankfurt June 2015 - Loof frankfurt symposium
Aegate Symposium Frankfurt June 2015 - Loof frankfurt symposium
 

Viewers also liked

Foss Meeting Presentation Sulaf
Foss Meeting Presentation SulafFoss Meeting Presentation Sulaf
Foss Meeting Presentation Sulafsulafassi
 
National Medicines Quality Control Laboratories (NMQCLs) and national network...
National Medicines Quality Control Laboratories (NMQCLs) and national network...National Medicines Quality Control Laboratories (NMQCLs) and national network...
National Medicines Quality Control Laboratories (NMQCLs) and national network...Wubshet Mamo
 
Graduate institute qse 14 feb ppt 1
Graduate institute qse 14 feb ppt 1Graduate institute qse 14 feb ppt 1
Graduate institute qse 14 feb ppt 1Nirmalya Syam
 

Viewers also liked (13)

Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...
 
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe MedicinesAfternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines
 
The Complex Journey of a Vaccine
The Complex Journey of a VaccineThe Complex Journey of a Vaccine
The Complex Journey of a Vaccine
 
IFPA Psoriasis Presentation
IFPA Psoriasis PresentationIFPA Psoriasis Presentation
IFPA Psoriasis Presentation
 
International Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'DellInternational Psoriasis Council, Steve O'Dell
International Psoriasis Council, Steve O'Dell
 
Foss Meeting Presentation Sulaf
Foss Meeting Presentation SulafFoss Meeting Presentation Sulaf
Foss Meeting Presentation Sulaf
 
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a VaccineIFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine
 
Manaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income CountriesManaement of Psoriasis in Low Income Countries
Manaement of Psoriasis in Low Income Countries
 
Peter Hotez, Baylor College of Medicine
Peter Hotez,  Baylor College of MedicinePeter Hotez,  Baylor College of Medicine
Peter Hotez, Baylor College of Medicine
 
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...
 
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo PharmaBringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma
 
National Medicines Quality Control Laboratories (NMQCLs) and national network...
National Medicines Quality Control Laboratories (NMQCLs) and national network...National Medicines Quality Control Laboratories (NMQCLs) and national network...
National Medicines Quality Control Laboratories (NMQCLs) and national network...
 
Graduate institute qse 14 feb ppt 1
Graduate institute qse 14 feb ppt 1Graduate institute qse 14 feb ppt 1
Graduate institute qse 14 feb ppt 1
 

Similar to Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /

Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines IndiaLuncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines IndiaThe Partnership For Safe Medicines
 
Health literate consumer
Health literate consumerHealth literate consumer
Health literate consumerlhattendorf
 
Introduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxIntroduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxDnyaneshwariMate1
 
Super Specialty Communication
Super Specialty CommunicationSuper Specialty Communication
Super Specialty Communicationkamalteamwork
 
Quality Use of Medicines
Quality Use of MedicinesQuality Use of Medicines
Quality Use of Medicineskbaskett
 
American Family chapter 3 - Understanding Health Care
American Family chapter 3 - Understanding Health CareAmerican Family chapter 3 - Understanding Health Care
American Family chapter 3 - Understanding Health Carebartlettfcs
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015Wildfrontech
 
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامت
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامتکارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامت
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامتTUMSup
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organizationDr. Zubair Ali
 
The Mexico City Principles
The Mexico City PrinciplesThe Mexico City Principles
The Mexico City PrinciplesSavior Lava
 
Healthcare is Getting Disrupted... Is Pharmacy Ready?
Healthcare is Getting Disrupted... Is Pharmacy Ready?Healthcare is Getting Disrupted... Is Pharmacy Ready?
Healthcare is Getting Disrupted... Is Pharmacy Ready?Hillary Blackburn
 
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...Surinder Thakur
 
Global Health Presentation
Global Health PresentationGlobal Health Presentation
Global Health Presentationmichaelhseid
 

Similar to Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA / (20)

Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines IndiaLuncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
 
Pv
PvPv
Pv
 
Health literate consumer
Health literate consumerHealth literate consumer
Health literate consumer
 
Introduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptxIntroduction to Quality use of medicine.pptx
Introduction to Quality use of medicine.pptx
 
Super Specialty Communication
Super Specialty CommunicationSuper Specialty Communication
Super Specialty Communication
 
Quality Use of Medicines
Quality Use of MedicinesQuality Use of Medicines
Quality Use of Medicines
 
Patient centric strategy
Patient centric strategyPatient centric strategy
Patient centric strategy
 
Pharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient SafetyPharmacovigilance: Partnering for Patient Safety
Pharmacovigilance: Partnering for Patient Safety
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
American Family chapter 3 - Understanding Health Care
American Family chapter 3 - Understanding Health CareAmerican Family chapter 3 - Understanding Health Care
American Family chapter 3 - Understanding Health Care
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامت
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامتکارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامت
کارگاه دهم تامزآپ 98- بازاریابی در حوزه سلامت
 
Mirfin-Mpundu-Session-1B-CCIH-2017
Mirfin-Mpundu-Session-1B-CCIH-2017Mirfin-Mpundu-Session-1B-CCIH-2017
Mirfin-Mpundu-Session-1B-CCIH-2017
 
Medical affairs department for small organization
Medical affairs department for small organizationMedical affairs department for small organization
Medical affairs department for small organization
 
The Mexico City Principles
The Mexico City PrinciplesThe Mexico City Principles
The Mexico City Principles
 
Healthcare is Getting Disrupted... Is Pharmacy Ready?
Healthcare is Getting Disrupted... Is Pharmacy Ready?Healthcare is Getting Disrupted... Is Pharmacy Ready?
Healthcare is Getting Disrupted... Is Pharmacy Ready?
 
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...
Promoting Healthcare Awareness And Patient Education Through Pharma Franchise...
 
Global Health Presentation
Global Health PresentationGlobal Health Presentation
Global Health Presentation
 
Social media and pharma
Social media and pharmaSocial media and pharma
Social media and pharma
 

More from International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

More from International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (11)

13 carlo pini superior institute of italy
13 carlo pini   superior institute of italy13 carlo pini   superior institute of italy
13 carlo pini superior institute of italy
 
15. Elki Sollenbring - Uppsala Monitoring Centre
15. Elki Sollenbring -  Uppsala Monitoring Centre15. Elki Sollenbring -  Uppsala Monitoring Centre
15. Elki Sollenbring - Uppsala Monitoring Centre
 
21. Maurice Mayrides - Esperantra
21. Maurice Mayrides -  Esperantra21. Maurice Mayrides -  Esperantra
21. Maurice Mayrides - Esperantra
 
20. Ubier Gomez - University of Antioquia
20. Ubier Gomez - University of Antioquia20. Ubier Gomez - University of Antioquia
20. Ubier Gomez - University of Antioquia
 
19. Agnes Klein - Health Canada
19. Agnes Klein - Health Canada19. Agnes Klein - Health Canada
19. Agnes Klein - Health Canada
 
18. Raffaella Balocco - WHO
18. Raffaella Balocco - WHO18. Raffaella Balocco - WHO
18. Raffaella Balocco - WHO
 
17. Gino Grampp - Amgen
17. Gino Grampp - Amgen17. Gino Grampp - Amgen
17. Gino Grampp - Amgen
 
16. Malin Fladvad - Uppsala Monitoring Centre
16. Malin Fladvad - Uppsala Monitoring Centre16. Malin Fladvad - Uppsala Monitoring Centre
16. Malin Fladvad - Uppsala Monitoring Centre
 
14. Laura Castanheira - Anvisa
14. Laura Castanheira -  Anvisa14. Laura Castanheira -  Anvisa
14. Laura Castanheira - Anvisa
 
9 Karin Heidenreich - Novartis
9 Karin Heidenreich -  Novartis9 Karin Heidenreich -  Novartis
9 Karin Heidenreich - Novartis
 
12 Dr. Thomas Schreitmueller Roche
12 Dr. Thomas Schreitmueller   Roche12 Dr. Thomas Schreitmueller   Roche
12 Dr. Thomas Schreitmueller Roche
 

Recently uploaded

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramLevi Shapiro
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...kevinkariuki227
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Dr. Aryan (Anish Dhakal)
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCatherine Liao
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyDr KHALID B.M
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAkashGanganePatil1
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxBright Chipili
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Catherine Liao
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Catherine Liao
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Catherine Liao
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMeenakshiGursamy
 

Recently uploaded (20)

Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 

Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /

  • 1. Collaboration Within and between Countries “Working together against Fake Medicines” by Bejon Misra, Founder Director Partner for Safe Medicines (PSM) India Friday 6th February 2015 Taipei, Taiwan
  • 2. Mission • A public health group committed to the safety of prescription drugs and protecting consumers against spurious and not-of- standards or otherwise unsafe medicines Vision • Just One Unsafe Medicine Threatens Patient Safety… we all must work together to educate and to help protect patients in India and around the globe PSM India
  • 3. Overarching Objectives •To adopt modern technology to empower and enable Indian consumers to access safe medicines as a patient’s right to safety and informed choice •To integrate spurious with not-of-standards and unsafe medicines as per the existing laws in India •To ensure consumer safety prevails as the priority by engaging with all the stakeholders in an equitable manner, with a focus on the poor and vulnerable consumers in India
  • 4. PSM India Board of Trustees 1. Secretary General, Indian Medical Association (IMA) 2. Former President, All India Women’s Conference (AIWC) 3. Former Chief Information Commissioner, Govt. of India, Chairman 4. Chairman of Healthy You Foundation (Consumer Organisation) 5. Supreme Court Of India Advocate 6. Former Secretary to the Govt. of India 7. Founder & Trustee, Consumer Online Foundation 8. Former Chief of Customs & Excise, Govt. of India 9. WHO Consultant 10. Pharmaceutical Regulatory Consultant 11. Medical Practitioner and Retired from Indian Defence Services 12. Former Vice President of International Pharmaceutical Federation 13. Director, Cell for Consumer Education and Advocacy 14. Founder of Private Hospital Dealing with Emergency Care, Vice Chairman 15. Chairman, THINK TANK Pharma Industry Forum 15 Members with Broad Experience
  • 5. PSM India: The Beginning • Concept: – Emerged from brainstorming session organized by PSM USA based on individual meetings with key stakeholders with interest in PSM • Steering Committee: – Formal board members based on organization meeting prior to launch • Immediate Goals: – Build strong coalition with all stakeholders engaged in the medicine supply chain – Make PSM patient centric with support from government – Make PSM dedicated to patient safety, quality medicines & healthcare
  • 6. Building PSM India • Process: – Consulted and re-consulted the stakeholders, especially government and consumer/patient groups, to build PSM toward addressing key concerns about unsafe medicines – For board members, identified individuals and organizations with an excellent track record on its competence and reach. Ensured participation by entities in the medicine supply chain • Government involvement – Government officials always invited to Board meetings even though they are not board members – Joint educational and outreach activities with PSM – Co-share resources for organizing events, workshops and training initiatives • Other stakeholders – Lawyers, law enforcers, research institutions also invited as observers
  • 7. Lessons Learned • Put forward PSM objectives in open manner and engage all stakeholders from the beginning to build support and cooperation • Create good vibrant website with regular newsletter to push out • Organize events on range of health care topics, but connect to the issue of tackling counterfeit medicines in the supply chain • Maintain regular connection with government • Recognize and give credit to organizations playing a positive role in advancing the objectives of PSM
  • 8. Advice for Similar Alliances in other Countries • Make sure the PSM is driven by local leadership and interests • Do not allow PSM to be viewed as an initiative of any one Cluster or sector • Avoid straying into issues that are not clearly related to the fight against fake medicines and educating the public about the risks • Do not make it look like a club of a few elite institutions or individuals • Do not ignore your detractors or critics
  • 9.  Aggressive but well-calibrated organization led to successful partnerships including all levels of Indian government  Indian pharmaceutical industry buy-in  Public education campaign with regular Newsletter, dynamic website and toll-free 24/7 Helpline  As a result, Indian consumers finally have the ability to educate themselves on the dangers of fake medicines  Indian government is more aware of risks and more willing to crack down on counterfeit producers PSM India: Progress
  • 10.
  • 11. PSM India: The Future Connect and empower the consumer: • More than 900 million consumers have mobile phones in India • More than 1 billion consumers with access to television/radio What and how to communicate? • How to procure safe medicines (generic & branded) from secured sources • Educate consumers to report adverse reactions from medicines • Strengthen the national pharmacovigilance system • Create champions as whistleblowers to report unethical practices and expose the culprits
  • 12. PSM India to Work on Patient’s Charter on Access to Safe Medicines Standards Choice Accessibility Non-discrimination Transparency Accountability Information Quality of service
  • 13. Consumer Empowerment is the Key Demo manufacturer authenticates genuine pack of XXXX. Batch No. XXXX Thank you for verifying your
  • 14.